...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Additional Exempt Distribution- 2023-05-11
 

Alberta: 1 Promissory Note  Cdn $175,000.00 

225,000  Warrants @ $0.75 expire 2028-05-11
 
 
Koo

 

 

Share
New Message
Please login to post a reply